Answer extracted from The Single Source podcast — listen to the full episode below.
Why does cannabis private credit offer portfolio diversification benefits for income allocators?
Cannabis yields are completely uncorrelated from both the broader private credit market and interest rate movements, delivering high returns that move independently of traditional credit dynamics. This uncorrelated profile makes cannabis an attractive hedge for allocators building diversified income strategies, since returns don't depend on the macroeconomic forces that drive other credit investments.
The core appeal lies in what economists call the correlation coefficient—cannabis lending performance operates in its own market cycle. When broader private credit markets tighten due to rising rates or credit stress, cannabis yields remain stable. Conversely, as traditional credit spreads compress during risk-on periods, cannabis operators still generate consistent cash flows based on their own business fundamentals rather than systemic credit conditions.
This independence matters enormously for portfolio construction. As Brendan Fay explains in the episode, allocators seeking exposure to private credit typically face intense competition that drives pricing down across the entire market. Cannabis lending, however, operates in a credit-starved environment where there is far less competition, allowing lenders to capture premium returns without the correlation drag that traditional credit brings to a portfolio.
The maturity wall in cannabis also reinforces this opportunity. The cannabis industry faces a $5.4 billion maturity wall due within the next 24 months, yet conventional lenders have largely withdrawn from the sector. This creates an addressable lending opportunity where Coda Capital and similar specialists can deploy capital at attractive risk-adjusted returns precisely because supply and demand dynamics favor the lender rather than competing away the spread.
"Lenders in this space are going to be price setters rather than price takers, whereas in a lot of other private credit industries there's so much competition that private credit firms are price takers instead."
Brendan Fay — Founder and CIO, Coda Capital. Fay was diagnosed with rheumatoid arthritis four and a half years ago and discovered that medical marijuana transformed his condition from debilitating pain into functional wellness. This personal experience led him to partner with an owner-operator vertically integrated across cannabis cultivation, manufacturing, and retail in Missouri, ultimately founding Coda Capital to address the structural shortage of high-quality credit providers in the cannabis industry.
From a portfolio-construction lens, uncorrelated returns also reduce overall volatility. If a diversified allocator holds 60% traditional private credit and 20% cannabis credit alongside other assets, the non-correlation means drawdowns in broader credit markets don't drag down the entire portfolio equally. Cannabis lending returns cushion the overall impact, a property that traditional credit-on-credit diversification cannot deliver.
The regulatory tailwind further supports sustained uncorrelated performance. Recent rescheduling developments signal a shift in federal treatment that could reshape cannabis economics, potentially widening the addressable universe and sustaining the favorable supply-demand dynamics that currently define the sector.
The scarcity advantage in limited-license markets
Cannabis operates differently from most private credit verticals because state-level licensing creates artificial scarcity. Limited-license jurisdictions constrain the number of operators allowed to cultivate, manufacture, or retail, which protects incumbents and ensures the operators who need credit are genuinely limited in their alternatives. This scarcity translates directly into better underwriting outcomes and more durable cash flows.
In traditional private credit, hundreds of borrowers compete for capital, and spreads compress as lenders chase deal volume. In cannabis, the reverse dynamic emerges: a finite universe of licensed operators must secure refinancing, and conventional lenders have largely abandoned the sector. Allocators who provide capital to these operators earn a scarcity premium while remaining uncorrelated from broader credit markets, making it one of the few pockets where income and diversification align without sacrifice.
Key takeaways
- Cannabis lending yields operate completely independently of interest rates and broader private credit market conditions, providing genuine diversification for income portfolios.
- Limited-license state structures create scarcity value and protect borrower cash flows, enabling lenders to capture premium returns with lower correlation risk.
- The sector faces a $5.4 billion maturity wall in the next 24 months with minimal conventional capital available, positioning specialist lenders as price-setters rather than price-takers.
- Regulatory rescheduling developments could expand the addressable market while maintaining the uncorrelated dynamics that currently define cannabis credit returns.
See also
What differentiates an owner-operator cannabis credit manager in terms of underwriting expertise?
Brendan Fay's partner built a cannabis business from the application phase to over $20 million in EBITDA, providing direct expertise across cultivation, manufacturing, and retail operations in a vertically integrated structure.
What regulatory change expands the addressable market for cannabis credit underwriting?
Rescheduling of cannabis removes the federal 280E tax treatment that taxed operators at gross margin rather than net income, a situation where 70% of operator profits historically went to the US government.
How does cannabis private credit leverage differ from traditional private credit market approaches?
Cannabis private credit funds target equity returns at two times leverage or less, whereas other private credit firms typically employ five to ten times EBITDA, reflecting the different risk and return profiles of the sector.